Stryker's $2 Billion Play for Howmedica
Executive Summary
Whether Stryker Corp.'s recent $1.9 billion offer for Howmedica, the orthopedic implant business put up for sale by Pfizer, represents a continuation of the much-anticipated consolidation in orthopedics or simply an opportunistic play, remains to be seen.